Inflammatory myofibroblastic tumors are commonly seen in young adults and adolescents and commonly present with painless hematuria. We report a case of a 38-year-old woman who presented to us with urinary retention due to a prolapsing tumor mass from the urethra, which was discovered to be an inflammatory myofibroblastic tumor arising from the bladder base and involving the bladder neck. The patient underwent a successful transurethral resection of the tumor and at 6-month follow-up was continent and symptom-free.

Keywords:
Inflammatory myofibroblastic tumor, Prolapsing urethral mass, Urinary retention, Continence
1.
Roth JA: Reactive pseudosarcomatous response in urinary bladder. Urology 1980;16:635-637.
2.
Lott S, Lopez-Beltran A, Maclennan GT, Montironi R, Cheng L: Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807-823.
3.
Jones EC, Clement PB, Young RH: Inflammatory pseudotumor of the urinary bladder: a clinicopathological, immunohistochemical, ultrastructural, and flow cytometric study of 13 cases. Am J Surg Pathol 1993;17:264-274.
4.
Rasalkar DD, Chu WCW, To K, Cheng FWT, Li CK: Radiological appearance of inflammatory myofibroblastic tumour. Pediatr Blood Cancer 2010;54:1029-1031.
5.
Mevcha A, Drake MJ: Etiology and management of urinary retention in women. Indian J Urol 2010;26:230-235.
6.
Süer E, Gülpınar O, Mermerkaya M, et al: Inflammatory myofibroblastic tumor of the bladder in a 10-year-old girl. Urology 2012;80:1138-1140.
7.
Kim HW, Choi YH, Kang SM, et al: Malignant inflammatory myofibroblastic tumor of the bladder with rapid progression. Korean J Urol 2012;53:657-661.
8.
Pettinato G, Manivel JC, Rosa ND, Dehner LP: Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990;94:538-546.
9.
Rao RN, Ranjan P, Singla N, Pandey R: Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining. Urol Ann 2012;4:115-118.
10.
Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, et al: Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol 2007;20:592-603.
11.
Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, et al: Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006;30:1502-1512.
12.
Berger A, Kim C, Hagstrom N, Ferrer F: Successful preoperative treatment of pediatric bladder inflammatory myofibroblastic tumor with anti-inflammatory therapy. Urology 2007;70:372.e13-372.e15.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.